ImmuCell Corporation (ICCC)
NASDAQ·Healthcare·Biotechnology
$8.38
+1.58%
Mkt Cap $58.62M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $5.40M | $7.63M | +41.20% | $0.05 | -$0.31 | -720.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | $5.51M | — | — | -$0.02 | — | — | — |
| Q3 2025 Aug 14, 2025 | — | $6.44M | — | — | $0.06 | — | — | — |
| Q2 2025 May 14, 2025 | — | $8.07M | — | — | $0.16 | — | — | — |
| Q1 2025 Feb 25, 2025 | — | $7.75M | — | — | $0.06 | — | — | — |
| Q4 2024 Nov 13, 2024 | — | $6.01M | — | — | -$0.09 | — | — | — |
| Q3 2024 Aug 13, 2024 | $5.40M | $5.47M | +1.35% | — | -$0.20 | — | — | — |
| Q2 2024 May 14, 2024 | $5.40M | $7.26M | +34.40% | — | -$0.06 | — | — | — |
| Q1 2024 Feb 27, 2024 | $5.40M | $5.10M | -5.63% | — | -$0.15 | — | — | — |
| Q4 2023 Nov 13, 2023 | $5.40M | $5.40M | -0.06% | — | -$0.12 | — | — | — |
| Q3 2023 Aug 10, 2023 | $5.40M | $3.53M | -34.58% | — | -$0.18 | — | — | — |
| Q2 2023 May 11, 2023 | $5.40M | $3.45M | -36.18% | — | -$0.30 | — | — | — |
| Q1 2023 Feb 21, 2023 | $5.40M | $3.91M | -27.58% | — | -$0.22 | — | — | — |
| Q4 2022 Nov 21, 2022 | $5.40M | $4.80M | -11.19% | — | -$0.08 | — | — | — |
| Q3 2022 Aug 11, 2022 | $5.40M | $3.86M | -28.49% | — | -$0.09 | — | — | — |
| Q1 2022 Feb 22, 2022 | $5.40M | $5.44M | +0.81% | -$0.01 | $0.01 | +200.00% | — | — |
| Q4 2021 Nov 15, 2021 | $3.59M | $5.15M | +43.30% | -$0.06 | $0.02 | +133.33% | — | — |
| Q3 2021 Aug 12, 2021 | $3.26M | $4.54M | +39.19% | -$0.08 | $0.02 | +125.00% | — | — |
| Q2 2021 May 13, 2021 | $5.40M | $4.11M | -23.96% | $0.05 | -$0.06 | -220.00% | — | — |
| Q1 2021 Feb 22, 2021 | $9.26M | $3.74M | -59.60% | $0.01 | $0.03 | +174.98% | — | — |